在环境暴露于野火烟雾后使用喘药物:系统性审查
Cathy Etherington1, Anne-Marie Rushby2, Van Nguyen2
1National Centre for Epidemiology and Population Health, Australian National University, 62 Mills Road, Acton, ACT, 2601, Australia.
Environmental research
|April 10, 2025
概括
野火烟雾显著增加了喘药物的使用,特别是像萨尔布塔摩尔这样的缓解吸入剂. 这突显了由于气候变化驱动的野火,需要医疗准备.
科学领域:
- 环境健康 环境健康
- 呼吸系统医学 呼吸系统医学
- 公共卫生 公共卫生
背景情况:
- 喘是一种慢性呼吸道疾病,由空气污染加剧.
- 景观火灾释放的颗粒物 (PM2.5) 与健康不良结果有关.
- 气候变化正在增加野火的频率和强度.
研究的目的:
- 系统地审查风景火灾烟雾暴露和喘药物使用之间的关联.
- 为了澄清这种关系的方向和规模.
- 为了告知医疗保健系统对野火事件的准备.
主要方法:
- 对PubMed,Scopus和Web of Science数据库进行系统审查.
- 包括审查喘药物使用,野火后暴露于烟雾的同行评审文章.
- 分析了12篇已识别的文章,包括5个回顾性队列研究.
主要成果:
- 一致的证据表明,野火烟雾暴露后喘药物的使用增加.
- 缓解药物,特别是沙布塔摩尔,使用量显著增加.
- 对其他喘管理药物的需求也持续增加.
结论:
- 野火烟雾暴露与喘药物需求增加密切相关.
- 医疗保健系统必须为喘药物需求的激增做好准备.
- 应对气候变化对于减轻野火对公共健康的影响至关重要.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
278
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
278
Asthma: Pathogenesis and Management
259
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
259
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
165
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
165


